News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Internal C.R. Bard Memo Shows Medical Device Company Knew Mesh Was Unfit for Humans


6/27/2013 8:05:50 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Recently unsealed documents in personal injury lawsuits filed against C.R. Bard over its transvaginal mesh implants show that company executives knew the plastic used in the mesh was unfit for implantation into humans. C.R. Bard (NYSE:BCR) ignored warnings that the plastic used in its transvaginal mesh implants was unfit for use in humans, according to court documents recently unsealed in personal injury lawsuits filed against the medical device company. The manufacturer of the plastic used in Bard's Avaulta mesh implant for hernia repair warned that it wasn't suitable for implantation, according to the documents. Bard executives sought to conceal the use of the plastic from its manufacturer, a division of Chevron Phillips Chemical Co., according to the records.

Help employers find you! Check out all the jobs and post your resume.

Read at MassDevice
Read at nj.com

comments powered by Disqus
MassDevice
nj.com
C.R. Bard
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES